{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:56:12Z","timestamp":1790142972273,"version":"4.0.1"},"reference-count":221,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejmech.2025.117508","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T12:11:08Z","timestamp":1741954268000},"page":"117508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The potential capacities of FTY720: Novel therapeutic functions, targets, and mechanisms against diseases"],"prefix":"10.1016","volume":"290","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9723-7132","authenticated-orcid":false,"given":"Juan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117508_bib1","doi-asserted-by":"crossref","first-page":"a032011","DOI":"10.1101\/cshperspect.a032011","article-title":"Oral therapies for multiple sclerosis","volume":"9","author":"Faissner","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ejmech.2025.117508_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40263-021-00798-w","article-title":"Sphingosine 1-phosphate receptor modulators for multiple sclerosis","volume":"35","author":"Roy","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejmech.2025.117508_bib3","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/jnnp-2023-331499","article-title":"Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial","volume":"94","author":"Diouf","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejmech.2025.117508_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.7164\/antibiotics.47.208","article-title":"Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite","volume":"47","author":"Fujita","year":"1994","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2025.117508_bib5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41429-020-0351-0","article-title":"Discovery of fingolimod based on the chemical modification of a natural product from the fungus, Isaria sinclairii","volume":"73","author":"Chiba","year":"2020","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2025.117508_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cbpa.2016.04.014","article-title":"From natural product to the first oral treatment for multiple sclerosis: the discovery of FTY720 (GilenyaTM)?","volume":"32","author":"Z\u00e9cri","year":"2016","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117508_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300387","article-title":"Structural determinants of sphingosine-1-phosphate receptor selectivity","volume":"356","author":"Wunsch","year":"2023","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2025.117508_bib8","doi-asserted-by":"crossref","first-page":"47408","DOI":"10.1074\/jbc.M307687200","article-title":"Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases","volume":"278","author":"Billich","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117508_bib9","unstructured":"Fingolimod Phosphate (FTY720-P) Activates Protein Phosphatase 2A in Human Monocytes and Inhibits Monosodium Urate Crystal-Induced Interleukin-1 \u03b2 Production - PubMed, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/33239408\/(accessed October 27, 2024)."},{"key":"10.1016\/j.ejmech.2025.117508_bib10","article-title":"Structure of S1PR2-heterotrimeric G13 signaling complex","volume":"8","author":"Chen","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.117508_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/2211-5463.13907","article-title":"Unique pharmacological properties of etrasimod among S1P receptor modulators","volume":"15","author":"Gaidarov","year":"2025","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ejmech.2025.117508_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1139\/bcb-2016-0025","article-title":"FTY720P inhibits hepatic Na(+)-K(+) ATPase via S1PR2 and PGE2","volume":"94","author":"Al Alam","year":"2016","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.ejmech.2025.117508_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/1087057113502234","article-title":"No differences observed among multiple clinical S1P1 receptor agonists (functional antagonists) in S1P1 receptor down-regulation and degradation","volume":"19","author":"Lukas","year":"2014","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejmech.2025.117508_bib14","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1111\/bph.12620","article-title":"Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalization","volume":"171","author":"Sykes","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117508_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41589-021-00930-3","article-title":"Structural basis of sphingosine-1-phosphate receptor 1 activation and biased agonism","volume":"18","author":"Xu","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117508_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2117716119","article-title":"Structural insights into sphingosine-1-phosphate receptor activation","volume":"119","author":"Yu","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.117508_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/17425255.2022.2138330","article-title":"Current status and new developments in sphingosine-1-phosphate receptor antagonism: fingolimod and more","volume":"18","author":"Constantinescu","year":"2022","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117508_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41589-021-00930-3","article-title":"Structural basis of sphingosine-1-phosphate receptor 1 activation and biased agonism","volume":"18","author":"Xu","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117508_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.sbi.2017.05.001","article-title":"Structural mechanism of arrestin activation","volume":"45","author":"Scheerer","year":"2017","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ejmech.2025.117508_bib20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.tcb.2017.05.008","article-title":"Novel structural insights into GPCR-\u03b2-arrestin interaction and signaling","volume":"27","author":"Ranjan","year":"2017","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117508_bib21","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/cdd.2017.121","article-title":"Blocking endothelin-1-receptor\/\u03b2-catenin circuit sensitizes to chemotherapy in colorectal cancer","volume":"24","author":"Cianfrocca","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2025.117508_bib22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/pharmrev.121.000302","article-title":"\u03b2-Arrestins: structure, function, physiology, and pharmacological perspectives","volume":"75","author":"Wess","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2025.117508_bib23","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1002\/jcp.30847","article-title":"Deciphering the signaling mechanisms of \u03b2-arrestin1 and \u03b2-arrestin2 in regulation of cancer cell cycle and metastasis","volume":"237","author":"Aamna","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejmech.2025.117508_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s12276-023-01144-4","article-title":"The multifaceted functions of \u03b2-arrestins and their therapeutic potential in neurodegenerative diseases","volume":"56","author":"Kee","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117508_bib25","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s40265-017-0814-1","article-title":"Benefit-risk profile of sphingosine-1-phosphate receptor modulators in relapsing and secondary progressive multiple sclerosis","volume":"77","author":"Comi","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2025.117508_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40265-017-0692-6","article-title":"The ocular manifestations of drugs used to treat multiple sclerosis","volume":"77","author":"Heath","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2025.117508_bib27","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200164","article-title":"Multiple sclerosis, disease-modifying therapies, and infections","volume":"10","author":"Langer-Gould","year":"2023","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ejmech.2025.117508_bib28","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/acn3.52017","article-title":"Sphingosine 1-phosphate receptor modulators in multiple sclerosis treatment: a practical review","volume":"11","author":"Coyle","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.ejmech.2025.117508_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.msard.2016.04.002","article-title":"Update on the cardiovascular profile of fingolimod in the therapy of relapsing-remitting multiple sclerosis (MS)","volume":"8","author":"Meissner","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.ejmech.2025.117508_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/cns.12283","article-title":"Vagomimetic effects of fingolimod: physiology and clinical implications","volume":"20","author":"Vanoli","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejmech.2025.117508_bib31","first-page":"80","article-title":"[Pharmacovigilance update]","volume":"17","author":"Ekobena","year":"2021","journal-title":"Rev. Med. Suisse"},{"key":"10.1016\/j.ejmech.2025.117508_bib32","first-page":"987","article-title":"Life-threatening asthma attack during prolonged fingolimod treatment: case report","volume":"8","author":"Zecca","year":"2014","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.ejmech.2025.117508_bib33","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/jamaneurol.2016.0826","article-title":"Rebound syndrome in patients with multiple sclerosis after cessation of fingolimod treatment","volume":"73","author":"Hatcher","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejmech.2025.117508_bib34","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1177\/1352458516645868","article-title":"Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod","volume":"22","author":"Papathemeli","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ejmech.2025.117508_bib35","article-title":"A case of presumed herpes keratouveitis in a patient treated with fingolimod","volume":"2","author":"Ayers","year":"2016","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1016\/j.ejmech.2025.117508_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-221819","article-title":"Ventricular tachycardia after initiation of fingolimod","volume":"2017","author":"Elounais","year":"2017","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ejmech.2025.117508_bib37","doi-asserted-by":"crossref","first-page":"e1815","DOI":"10.1212\/WNL.0000000000005529","article-title":"Progressive multifocal leukoencephalopathy after fingolimod treatment","volume":"90","author":"Berger","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2025.117508_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102180","article-title":"Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod","volume":"42","author":"Foerch","year":"2020","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"10.1016\/j.ejmech.2025.117508_bib39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40265-020-01431-8","article-title":"Sphingosine 1-phosphate receptor modulator therapy for multiple sclerosis: differential downstream receptor signalling and clinical profile effects","volume":"81","author":"Chun","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2025.117508_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119956","article-title":"Development of electrospun polymer scaffolds for the localized and controlled delivery of siponimod for the management of critical bone defects","volume":"590","author":"Sartawi","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2025.117508_bib41","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/leu.2016.244","article-title":"Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation","volume":"31","author":"McCracken","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2025.117508_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.chemphyslip.2015.10.004","article-title":"Pulmonary endothelial cell barrier enhancement by novel FTY720 analogs: methoxy-FTY720, fluoro-FTY720, and \u03b2-glucuronide-FTY720","volume":"194","author":"Camp","year":"2016","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejmech.2025.117508_bib43","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3390\/cells11132058","article-title":"Sphingosine-1-Phosphate (S1P) and S1P signaling pathway modulators, from current insights to future perspectives","volume":"11","author":"Bravo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117508_bib44","unstructured":"pi_zeposia.pdf, (n.d.). https:\/\/packageinserts.bms.com\/pi\/pi_zeposia.pdf (accessed April 30, 2024)."},{"key":"10.1016\/j.ejmech.2025.117508_bib45","article-title":"Neutrophil membrane-camouflaged polyprodrug nanomedicine for inflammation suppression in ischemic stroke therapy","volume":"36","author":"Zhao","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejmech.2025.117508_bib46","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.3390\/cells12192351","article-title":"Red-light-activatable AND-gated antitumor immunosuppressant","volume":"12","author":"Zhou","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117508_bib47","doi-asserted-by":"crossref","first-page":"39348","DOI":"10.1039\/D0RA06415G","article-title":"Ultrasound-mediated delivery of RGD-conjugated nanobubbles loaded with fingolimod and superparamagnetic iron oxide nanoparticles: targeting hepatocellular carcinoma and enhancing magnetic resonance imaging","volume":"10","author":"Guo","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117508_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4806541","article-title":"The role of sphingosine-1-phosphate and ceramide-1-phosphate in inflammation and cancer","volume":"2017","author":"Hait","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejmech.2025.117508_bib49","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI76369","article-title":"Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy","volume":"125","author":"Proia","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.117508_bib50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4168\/aair.2019.11.3.381","article-title":"Evaluation of neutrophil activation status according to the phenotypes of adult asthma","volume":"11","author":"Kim","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.ejmech.2025.117508_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2023.103304","article-title":"Blocking sphingosine 1-phosphate receptor 1 with modulators reduces immune cells infiltration and alleviates endometriosis in mice","volume":"47","author":"Zhang","year":"2023","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.ejmech.2025.117508_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aav1263","article-title":"CD4 T cell sphingosine 1-phosphate receptor (S1PR)1 and S1PR4 and endothelial S1PR2 regulate afferent lymphatic migration","volume":"4","author":"Xiong","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ejmech.2025.117508_bib53","article-title":"Targeting L-selectin lymphocytes to deliver immunosuppressive drug in lymph nodes for durable multiple sclerosis treatment","volume":"10","author":"Zhao","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejmech.2025.117508_bib54","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(21)00244-0","article-title":"Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions","volume":"398","author":"McGinley","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117508_bib55","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2400","article-title":"The alliance of sphingosine-1-phosphate and its receptors in immunity","volume":"8","author":"Rivera","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2025.117508_bib56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s42003-020-0752-4","article-title":"Combinatorial allosteric modulation of agonist response in a self-interacting G-protein coupled receptor","volume":"3","author":"Patrone","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejmech.2025.117508_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228380","article-title":"Treatment effects of fingolimod in multiple sclerosis: selective changes in peripheral blood lymphocyte subsets","volume":"15","author":"Hjorth","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.117508_bib58","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.2147\/OTT.S234394","article-title":"FTY720 suppresses liver tumor growth and metastasis by reducing circulating regulating T cells and enhancing the anti-tumor effect of rapamycin","volume":"13","author":"Li","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejmech.2025.117508_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350370","article-title":"The impact of fingolimod on Treg function in brain ischaemia","volume":"53","author":"Malone","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejmech.2025.117508_bib60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13075-015-0909-6","article-title":"The CII-specific autoimmune T-cell response develops in the presence of FTY720 but is regulated by enhanced Treg cells that inhibit the development of autoimmune arthritis","volume":"18","author":"Miller","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejmech.2025.117508_bib61","first-page":"211","article-title":"The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro","volume":"30","author":"Liu","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117508_bib62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/gfq480","article-title":"CD4+ CD25+ regulatory T cells partially mediate the beneficial effects of FTY720, a sphingosine-1-phosphate analogue, during ischaemia\/reperfusion-induced acute kidney injury","volume":"26","author":"Kim","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejmech.2025.117508_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136413","article-title":"Fingolimod protects against cerebral ischemia reperfusion injury in rats by reducing inflammatory cytokines and inhibiting the activation of p38 MAPK and NF-\u03baB signaling pathways","volume":"771","author":"Zhang","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2025.117508_bib64","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1089\/jir.2022.0078","article-title":"Rationale for use of sphingosine-1-phosphate receptor modulators in COVID-19 patients: overview of scientific evidence","volume":"43","author":"Hach","year":"2023","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.ejmech.2025.117508_bib65","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1194\/jlr.M067264","article-title":"Analysis of sphingolipids in human corneal fibroblasts from normal and keratoconus patients","volume":"58","author":"Qi","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejmech.2025.117508_bib66","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/fcp.12897","article-title":"FTY-720 alleviates diabetes-induced liver injury by inhibiting oxidative stress and inflammation","volume":"37","author":"Ye","year":"2023","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117508_bib67","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/kjm2.12570","article-title":"The protective role of FTY720 in promoting survival of allograft fat in mice","volume":"38","author":"Yi","year":"2022","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.ejmech.2025.117508_bib68","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.7861\/clinmed.2020-0309","article-title":"Rationale for the use of sphingosine analogues in COVID-19 patients","volume":"21","author":"Tasat","year":"2021","journal-title":"Clin. Med."},{"key":"10.1016\/j.ejmech.2025.117508_bib69","article-title":"S1P analogues SEW2871, BAF312 and FTY720 affect human Th17 and Treg generation ex vivo","volume":"107","author":"F","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.117508_bib70","article-title":"FTY720 attenuates angiotensin II-induced podocyte damage via inhibiting inflammatory cytokines","volume":"2017","author":"K","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejmech.2025.117508_bib71","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12964-024-01626-6","article-title":"Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-\u03b1 immunotherapy","volume":"22","author":"Sukocheva","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejmech.2025.117508_bib72","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/bs.ircmb.2020.02.004","article-title":"On the role of sphingolipids in cell survival and death","volume":"351","author":"Iessi","year":"2020","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.ejmech.2025.117508_bib73","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4062\/biomolther.2018.215","article-title":"Pro-inflammatory role of S1P3 in macrophages","volume":"27","author":"Heo","year":"2019","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.ejmech.2025.117508_bib74","article-title":"Sphingosine-1-Phosphate contributes to TLR9-induced TNF-\u03b1 release in lung tumor cells","volume":"55","author":"M","year":"2021","journal-title":"Cell. Physiol. Biochem. : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology"},{"key":"10.1016\/j.ejmech.2025.117508_bib75","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s00432-018-2765-7","article-title":"The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers","volume":"144","author":"Fujiki","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.117508_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2019.100670","article-title":"Sphingosine-1-phosphate signaling: a novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain","volume":"75","author":"Singh","year":"2020","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.ejmech.2025.117508_bib77","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.3390\/cells10113217","article-title":"Signaling through the S1P-S1PR Axis in the gut, the immune and the central nervous system in multiple sclerosis: implication for pathogenesis and treatment","volume":"10","author":"Chatzikonstantinou","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117508_bib78","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.107.127183","article-title":"Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis","volume":"323","author":"Foster","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2025.117508_bib79","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00109-019-01812-x","article-title":"Early central vs. peripheral immunological and neurobiological effects of fingolimod-a longitudinal study","volume":"97","author":"Sehr","year":"2019","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.ejmech.2025.117508_bib80","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419878324","article-title":"Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results","volume":"12","author":"Cohen","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.ejmech.2025.117508_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/srep35314","article-title":"Altered T cell phenotypes associated with clinical relapse of multiple sclerosis patients receiving fingolimod therapy","volume":"6","author":"Fujii","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117508_bib82","doi-asserted-by":"crossref","first-page":"S678","DOI":"10.1093\/ecco-jcc\/jjx107","article-title":"Targeting S1P in inflammatory bowel disease: new avenues for modulating intestinal leukocyte migration","volume":"12","author":"Danese","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ejmech.2025.117508_bib83","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.3390\/biomedicines10071735","article-title":"Sphingosine 1-phosphate modulation in inflammatory bowel diseases: keeping lymphocytes out of the intestine","volume":"10","author":"Dal Buono","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2025.117508_bib84","article-title":"Sphingosine-1-Phosphate signaling in immune cells and inflammation: roles and therapeutic potential","volume":"2016","author":"Aoki","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejmech.2025.117508_bib85","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s40265-021-01528-8","article-title":"Targeting sphingosine-1-phosphate signaling in immune-mediated diseases: beyond multiple sclerosis","volume":"81","author":"P\u00e9rez-Jeldres","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2025.117508_bib86","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/j.cgh.2022.03.035","article-title":"Ozanimod in the treatment of ulcerative colitis: initial real-world data from a large tertiary center","volume":"21","author":"Cohen","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117508_bib87","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/ecco-jcc\/jjad112","article-title":"Clinician's guide to using ozanimod for the treatment of ulcerative colitis","volume":"17","author":"Sands","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ejmech.2025.117508_bib88","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2019.04.022","article-title":"The S1P mimetic fingolimod phosphate regulates mitochondrial oxidative stress in neuronal cells","volume":"137","author":"Mart\u00edn-Monta\u00f1ez","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.117508_bib89","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/ijms25010261","article-title":"Investigating the mitoprotective effects of S1P receptor modulators ex vivo using a novel semi-automated live imaging set-up","volume":"25","author":"Ludwig","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117508_bib90","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuropharm.2018.02.023","article-title":"Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase","volume":"135","author":"Motyl","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2025.117508_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137596","article-title":"Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease","volume":"820","author":"Rajan","year":"2024","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2025.117508_bib92","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13426","article-title":"Sphingosine-1-phosphate in mitochondrial function and metabolic diseases","volume":"23","author":"Duan","year":"2022","journal-title":"Obes. Rev."},{"key":"10.1016\/j.ejmech.2025.117508_bib93","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.3390\/ijms24087374","article-title":"FTY720-P, a biased S1PR ligand, increases mitochondrial function through STAT3 activation in cardiac cells","volume":"24","author":"Mu\u00f1oz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117508_bib94","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbrc.2019.01.067","article-title":"Sphingosine-1-phosphate attenuates hypoxia\/reoxygenation-induced cardiomyocyte injury via a mitochondrial pathway","volume":"510","author":"Ke","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2025.117508_bib95","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1038\/s41598-017-05948-z","article-title":"Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion","volume":"7","author":"Darios","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117508_bib96","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41421-023-00613-4","article-title":"Qa-SNARE syntaxin 18 mediates lipid droplet fusion with SNAP23 and SEC22B","volume":"9","author":"Fu","year":"2023","journal-title":"Cell Discov"},{"key":"10.1016\/j.ejmech.2025.117508_bib97","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/ijms23031086","article-title":"Vesicle fusion as a target process for the action of sphingosine and its derived drugs","volume":"23","author":"Villanueva","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117508_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55106-w","article-title":"Multiple sclerosis drug FTY-720 toxicity is mediated by the heterotypic fusion of organelles in neuroendocrine cells","volume":"9","author":"Gimenez-Molina","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117508_bib99","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/jnc.14703","article-title":"Extracellular and intracellular sphingosine-1-phosphate distinctly regulates exocytosis in chromaffin cells","volume":"149","author":"Jiang","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2025.117508_bib100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-0716-1044-2_16","article-title":"Measurements of exocytosis by capacitance recordings and calcium uncaging in mouse adrenal chromaffin cells","volume":"2233","author":"Houy","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117508_bib101","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.3390\/ijms22042175","article-title":"Permissive modulation of sphingosine-1-phosphate-enhanced intracellular calcium on BKCa channel of chromaffin cells","volume":"22","author":"Wu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117508_bib102","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.biopha.2016.12.074","article-title":"Propofol inhibits LPS-induced apoptosis in lung epithelial cell line, BEAS-2B","volume":"87","author":"Lv","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117508_bib103","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.3390\/ijms23074010","article-title":"A rheostat of ceramide and sphingosine-1-phosphate as a determinant of oxidative stress-mediated kidney injury","volume":"23","author":"Ueda","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117508_bib104","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00109-023-02290-y","article-title":"Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivo","volume":"101","author":"Patel","year":"2023","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.ejmech.2025.117508_bib105","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3389\/fimmu.2020.01278","article-title":"FTY720 regulates mitochondria biogenesis in dendritic cells to prevent kidney ischemic reperfusion injury","volume":"11","author":"Rousselle","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117508_bib106","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.trim.2010.06.003","article-title":"FTY720 mediates cytochrome c release from mitochondria during rat thymocyte apoptosis","volume":"23","author":"Matsumura","year":"2010","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.ejmech.2025.117508_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2023.106425","article-title":"The role of vitamin D through SphK1\/S1P in the regulation of MS progression","volume":"236","author":"Wang","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117508_bib108","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174984","article-title":"S1PR1 inhibition induces proapoptotic signaling in T cells and limits humoral responses within lymph nodes","volume":"134","author":"Dixit","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.117508_bib109","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/S0041-1345(01)02314-4","article-title":"T-cell apoptosis triggered by FTY720 via mitochondrial pathway","volume":"33","author":"Fujino","year":"2001","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejmech.2025.117508_bib110","doi-asserted-by":"crossref","first-page":"12727","DOI":"10.1093\/nar\/gkaa1110","article-title":"Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism","volume":"48","author":"Chong","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.117508_bib111","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/cyto.a.20359","article-title":"Mechanism of mitochondrial 7A6 antigen exposure triggered by distinct apoptotic pathways: involvement of caspases","volume":"71","author":"Nagahara","year":"2007","journal-title":"Cytometry A"},{"key":"10.1016\/j.ejmech.2025.117508_bib112","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1042\/CS20200497","article-title":"Sphingosine-1-phosphate receptor modulator FTY720 attenuates experimental myeloperoxidase-ANCA vasculitis in a T cell-dependent manner","volume":"134","author":"Wang","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ejmech.2025.117508_bib113","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S1567-5769(01)00130-8","article-title":"Activation of caspases and mitochondria in FTY720-mediated apoptosis in human T cell line Jurkat","volume":"1","author":"Fujino","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.117508_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166888","article-title":"Inhibition of PP2A ameliorates intervertebral disc degeneration by reducing annulus fibrosus cells apoptosis via p38\/MAPK signal pathway","volume":"1870","author":"Zhu","year":"2024","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2025.117508_bib115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.lfs.2018.12.019","article-title":"FTY720 inhibits the activation of pancreatic stellate cells by promoting apoptosis and suppressing autophagy via the AMPK\/mTOR pathway","volume":"217","author":"Cui","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.117508_bib116","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/ptr.6968","article-title":"Curcumol and FTY720 synergistically induce apoptosis and differentiation in chronic myelomonocytic leukemia via multiple signaling pathways","volume":"35","author":"Zhao","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2025.117508_bib117","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s10495-013-0882-y","article-title":"FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors","volume":"18","author":"Kiyota","year":"2013","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2025.117508_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118077","article-title":"FTY720 induces ferroptosis and autophagy via PP2A\/AMPK pathway in multiple myeloma cells","volume":"260","author":"Zhong","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.117508_bib119","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1038\/s41598-017-06047-9","article-title":"FTY720 induces autophagy-associated apoptosis in human oral squamous carcinoma cells, in part, through a reactive oxygen species\/mcl-1-dependent mechanism","volume":"7","author":"Bai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117508_bib120","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1158\/1535-7163.MCT-20-0663","article-title":"PP2A-activating drugs enhance FLT3 inhibitor efficacy through AKT inhibition-dependent GSK-3\u03b2-mediated c-myc and pim-1 proteasomal degradation","volume":"20","author":"Scarpa","year":"2021","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2025.117508_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109282","article-title":"Pramipexole and Lactoferrin ameliorate Cyclophosphamide-Induced haemorrhagic cystitis via targeting Sphk1\/S1P\/MAPK, TLR-4\/NF-\u03baB, and NLRP3\/caspase-1\/IL-1\u03b2 signalling pathways and modulating the Nrf2\/HO-1 pathway","volume":"112","author":"Abdel Baky","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.117508_bib122","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-018-0823-2","article-title":"Protein phosphatase 2A activation mechanism contributes to JS-K induced caspase-dependent apoptosis in human hepatocellular carcinoma cells","volume":"37","author":"Liu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117508_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2019.12.015","article-title":"Nanoparticles carrying fingolimod and methotrexate enables targeted induction of apoptosis and immobilization of invasive thyroid cancer","volume":"148","author":"Niemel\u00e4","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejmech.2025.117508_bib124","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200339RRR","article-title":"Controlled mechanical loading improves bone regeneration by regulating type H vessels in a S1Pr1-dependent manner","volume":"36","author":"Yang","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2025.117508_bib125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCRESAHA.120.316711","article-title":"Endothelial S1P1 signaling counteracts infarct expansion in ischemic stroke","volume":"128","author":"Nitzsche","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2025.117508_bib126","doi-asserted-by":"crossref","first-page":"29367","DOI":"10.1074\/jbc.M403937200","article-title":"The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis","volume":"279","author":"Kono","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117508_bib127","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1161\/ATVBAHA.111.235408","article-title":"Pericyte-derived sphingosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier","volume":"31","author":"McGuire","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejmech.2025.117508_bib128","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/cells11060969","article-title":"Fingolimod (FTY720), a sphinogosine-1-phosphate receptor agonist, mitigates choroidal endothelial proangiogenic properties and choroidal neovascularization","volume":"11","author":"Sorenson","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117508_bib129","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.TR120000972","article-title":"Sphingolipids as critical players in retinal physiology and pathology","volume":"62","author":"Simon","year":"2021","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejmech.2025.117508_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112197","article-title":"Updates on sphingolipids: spotlight on retinopathy","volume":"143","author":"Shiwani","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.117508_bib131","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1021\/acs.analchem.7b04772","article-title":"Droplet array-based 3D coculture system for high-throughput tumor angiogenesis assay","volume":"90","author":"Du","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2025.117508_bib132","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1002\/ptr.7130","article-title":"Geniposide downregulates the VEGF\/SphK1\/S1P pathway and alleviates angiogenesis in rheumatoid arthritis in vivo and in vitro","volume":"35","author":"Wang","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2025.117508_bib133","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202200990","article-title":"A ROS-responsive liposomal composite hydrogel integrating improved mitochondrial function and pro-angiogenesis for efficient treatment of myocardial infarction","volume":"11","author":"Zheng","year":"2022","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.ejmech.2025.117508_bib134","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/1535-7163.MCT-16-0167","article-title":"FTY720 (fingolimod) inhibits HIF1 and HIF2 signaling, promotes vascular remodeling, and chemosensitizes in renal cell carcinoma animal model","volume":"15","author":"Gstalder","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2025.117508_bib135","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1038\/oncsis.2016.13","article-title":"Essential role for SphK1\/S1P signaling to regulate hypoxia-inducible factor 2\u03b1 expression and activity in cancer","volume":"5","author":"Bouquerel","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ejmech.2025.117508_bib136","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/jmri.27914","article-title":"USPIO-SWI shows fingolimod enhanced alteplase action on angiographic reperfusion in eMCAO rats","volume":"55","author":"Fu","year":"2022","journal-title":"J. Magn. Reson. Imag."},{"key":"10.1016\/j.ejmech.2025.117508_bib137","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/ATVBAHA.123.320339","article-title":"Microvascular network remodeling in the ischemic mouse brain defined by light sheet microscopy","volume":"44","author":"Hagemann","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejmech.2025.117508_bib138","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00784-023-05450-z","article-title":"Pleiotropic effect of intramucosal injection of FTY720 on angiogenesis and tissue healing after free gingival graft surgery: a comparative experimental study in rabbits","volume":"28","author":"Zarch","year":"2023","journal-title":"Clin. Oral Invest."},{"key":"10.1016\/j.ejmech.2025.117508_bib139","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fphar.2020.00059","article-title":"Non-mitogenic fibroblast growth factor 1 enhanced angiogenesis following ischemic stroke by regulating the sphingosine-1-phosphate 1 pathway","volume":"11","author":"Zou","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117508_bib140","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202207227","article-title":"Lymph-node-targeted drug delivery for effective immunomodulation to prolong the long-term survival after heart transplantation","volume":"35","author":"Che","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejmech.2025.117508_bib141","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92033","article-title":"CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients","volume":"2","author":"Khiew","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejmech.2025.117508_bib142","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/term.2464","article-title":"Local delivery of fingolimod from three-dimensional scaffolds impacts islet graft efficacy and microenvironment in a murine diabetic model","volume":"12","author":"Frei","year":"2018","journal-title":"J Tissue Eng Regen Med"},{"key":"10.1016\/j.ejmech.2025.117508_bib143","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/jbm.b.33862","article-title":"An engineered macroencapsulation membrane releasing FTY720 to precondition pancreatic islet transplantation","volume":"106","author":"Bowers","year":"2018","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.ejmech.2025.117508_bib144","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.amjms.2021.01.013","article-title":"Decline in publications on chronic rejection and graft vascular disease: a matter of concern","volume":"362","author":"Subbotin","year":"2021","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.ejmech.2025.117508_bib145","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1399-0012.2009.01070.x","article-title":"FTY720A2202 clinical study group, FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study","volume":"23","author":"Tedesco-Silva","year":"2009","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.ejmech.2025.117508_bib146","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1093\/ndt\/gfr503","article-title":"FTY720 Phase II Transplant Study Group, FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study","volume":"26","author":"Hoitsma","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejmech.2025.117508_bib147","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1177\/1933719119828112","article-title":"Sphingosine 1 phosphate (S1P) increased IL-6 expression and cell growth in endometriotic cells","volume":"26","author":"Yoshino","year":"2019","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.ejmech.2025.117508_bib148","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/bs.apcsb.2019.11.003","article-title":"Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease","volume":"120","author":"Sukocheva","year":"2020","journal-title":"Adv Protein Chem Struct Biol"},{"key":"10.1016\/j.ejmech.2025.117508_bib149","doi-asserted-by":"crossref","DOI":"10.1038\/srep37297","article-title":"The phosphorylated form of FTY720 activates PP2A, represses inflammation and is devoid of S1P agonism in A549 lung epithelial cells","volume":"6","author":"Rahman","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117508_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110017","article-title":"Comparative transcriptome profile of mouse macrophages treated with the RhoA\/Rock pathway inhibitors Y27632, Fingolimod (Gilenya), and Rezurock (Belumosudil, SLx-2119)","volume":"118","author":"Subuddhi","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.117508_bib151","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41419-019-1411-x","article-title":"S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.117508_bib152","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.intimp.2018.11.032","article-title":"S1P promotes inflammation-induced tube formation by HLECs via the S1PR1\/NF-\u03baB pathway","volume":"66","author":"Zheng","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.117508_bib153","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2147\/DDDT.S293876","article-title":"FTY720 inhibits the development of collagen-induced arthritis in mice by suppressing the recruitment of CD4+ T lymphocytes","volume":"15","author":"Zhu","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2025.117508_bib154","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3390\/cells11162524","article-title":"S1P-Induced TNF-\u03b1 and IL-6 release from PBMCs exacerbates lung cancer-associated inflammation","volume":"11","author":"Terlizzi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117508_bib155","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12967-020-02386-w","article-title":"FTY720 ameliorates GvHD by blocking T lymphocyte migration to target organs and by skin fibrosis inhibition","volume":"18","author":"Ryu","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.117508_bib156","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/cmi.2014.59","article-title":"The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment","volume":"12","author":"Cheng","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejmech.2025.117508_bib157","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660842","article-title":"A novel radioimmune 99mTc-labeled tracer for imaging sphingosine 1-phosphate receptor 1 in tumor xenografts: an in vitro and in vivo study","volume":"12","author":"Ye","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117508_bib158","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12967-023-04830-z","article-title":"Targeting the SphK1\/S1P\/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis","volume":"22","author":"Liu","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.117508_bib159","doi-asserted-by":"crossref","DOI":"10.1177\/1073274820976664","article-title":"The tumorigenic effect of sphingosine kinase 1 and its potential therapeutic target","volume":"27","author":"Wang","year":"2020","journal-title":"Cancer Control"},{"key":"10.1016\/j.ejmech.2025.117508_bib160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pharmthera.2018.10.011","article-title":"The sphingosine kinase-1\/sphingosine-1-phosphate axis in cancer: potential target for anticancer therapy","volume":"195","author":"Zheng","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.117508_bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-024-03221-8","article-title":"The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target","volume":"24","author":"Alkafaas","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejmech.2025.117508_bib162","doi-asserted-by":"crossref","first-page":"e695","DOI":"10.1002\/ctm2.695","article-title":"The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): a new targeted therapy of NEPC","volume":"12","author":"Lee","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.117508_bib163","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12935-023-03193-1","article-title":"Altering phosphorylation in cancer through PP2A modifiers","volume":"24","author":"Johnson","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejmech.2025.117508_bib164","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2478\/acph-2022-0029","article-title":"Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP\/TAZ suppression","volume":"72","author":"Du","year":"2022","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejmech.2025.117508_bib165","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.celrep.2016.10.019","article-title":"Sphingosine kinase 1 cooperates with autophagy to maintain endocytic membrane trafficking","volume":"17","author":"Young","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2025.117508_bib166","first-page":"942","article-title":"TP53 is required for BECN1- and ATG5-dependent cell death induced by sphingosine kinase 1 inhibition","volume":"14","author":"Lima","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2025.117508_bib167","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1016\/j.bmc.2016.07.038","article-title":"Effects of stereochemistry, saturation, and hydrocarbon chain length on the ability of synthetic constrained azacyclic sphingolipids to trigger nutrient transporter down-regulation, vacuolation, and cell death","volume":"24","author":"Perryman","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117508_bib168","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41419-019-2080-5","article-title":"FTY720 induces non-canonical phosphatidylserine externalization and cell death in acute myeloid leukemia","volume":"10","author":"Young","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.117508_bib169","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41375-019-0577-7","article-title":"Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice","volume":"34","author":"Vorbach","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2025.117508_bib170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11427-021-2123-8","article-title":"The repression of oncoprotein SET by the tumor suppressor p53 reveals a p53-SET-PP2A feedback loop for cancer therapy","volume":"66","author":"Yao","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.ejmech.2025.117508_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.10.007","article-title":"A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity","volume":"468","author":"Vicente","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2025.117508_bib172","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.1096\/fj.201802264R","article-title":"The NMR-based characterization of the FTY720-SET complex reveals an alternative mechanism for the attenuation of the inhibitory SET-PP2A interaction","volume":"33","author":"De Palma","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2025.117508_bib173","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12967-017-1158-z","article-title":"FTY720 inhibits mesothelioma growth in vitro and in a syngeneic mouse model","volume":"15","author":"Szymiczek","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.117508_bib174","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4161\/auto.19050","article-title":"FTY720-induced blockage of autophagy enhances anticancer efficacy of milatuzumab in mantle cell lymphoma: is FTY720 the next autophagy-blocking agent in lymphoma treatment?","volume":"8","author":"Alinari","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.ejmech.2025.117508_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.529962","article-title":"Coix seed oil exerts an anti-triple-negative breast cancer effect by disrupting miR-205\/S1PR1 Axis","volume":"11","author":"Fang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117508_bib176","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12951-021-00904-6","article-title":"The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1\/P-STAT3\/VEGFA axis in triple-negative breast cancer","volume":"19","author":"Gong","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ejmech.2025.117508_bib177","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3390\/cells9040886","article-title":"Sphingosine kinase 1 regulates the survival of breast cancer stem cells and non-stem breast cancer cells by suppression of STAT1","volume":"9","author":"Hii","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117508_bib178","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.18632\/oncotarget.1874","article-title":"SPHK1 regulates proliferation and survival responses in triple-negative breast cancer","volume":"5","author":"Datta","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2025.117508_bib179","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/cells12070980","article-title":"S1P1 threonine 236 phosphorylation mediates the invasiveness of triple-negative breast cancer and sensitivity to FTY720","volume":"12","author":"Laroche","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117508_bib180","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature08710","article-title":"Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology","volume":"463","author":"Kirkegaard","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117508_bib181","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3892\/or.2021.8251","article-title":"Lysosome-targeted drug combination induces multiple organelle dysfunctions and non-canonical death in pancreatic cancer cells","volume":"47","author":"Suzuki","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2025.117508_bib182","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s12975-020-00789-x","article-title":"FTY720 protects against ischemia-reperfusion injury by preventing the redistribution of tight junction proteins and decreases inflammation in the subacute phase in an experimental stroke model","volume":"11","author":"Wang","year":"2020","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.ejmech.2025.117508_bib183","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/bph.15954","article-title":"Fingolimod ameliorates schizophrenia-like cognitive impairments induced by phencyclidine in male rats","volume":"180","author":"Yu","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117508_bib184","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg7863","article-title":"Learning CNS immunopathology from therapeutic interventions","volume":"15","author":"Schwab","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.117508_bib185","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157738","article-title":"Sphingosine-1-phosphate receptor 1 activation in the central nervous system drives cisplatin-induced cognitive impairment","volume":"132","author":"Squillace","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.117508_bib186","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1006\/taap.1996.8029","article-title":"Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology","volume":"142","author":"Merrill","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117508_bib187","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.972","article-title":"The efficacy and safety of fingolimod plus standardized treatment versus standardized treatment alone for acute ischemic stroke: a systematic review and meta-analysis","volume":"10","author":"Bai","year":"2022","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.ejmech.2025.117508_bib188","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mus.25733","article-title":"Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability","volume":"56","author":"Berry","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejmech.2025.117508_bib189","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1084\/jem.20170584","article-title":"Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain","volume":"215","author":"Stockstill","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejmech.2025.117508_bib190","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(18)30202-3","article-title":"FORCIDP Trial Investigators, Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial","volume":"17","author":"Hughes","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2025.117508_bib191","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.25352","article-title":"Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow","volume":"84","author":"Tian","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejmech.2025.117508_bib192","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jamaneurol.2014.1065","article-title":"Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study","volume":"71","author":"Fu","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejmech.2025.117508_bib193","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.016371","article-title":"Combination of the immune modulator fingolimod with alteplase in acute ischemic stroke: a pilot trial","volume":"132","author":"Zhu","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2025.117508_bib194","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00702-023-02618-5","article-title":"Repurposing drugs against Alzheimer's disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?","volume":"130","author":"Le\u00dfmann","year":"2023","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejmech.2025.117508_bib195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1021\/acschemneuro.3c00545","article-title":"FTY720 nanoformulation induces O-GlcNacylation of synuclein to alleviate synucleinopathy","volume":"15","author":"Sardoiwala","year":"2024","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.117508_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107511","article-title":"Prophylactic administration of fingolimod (FTY720) ameliorated experimental autoimmune myasthenia gravis by reducing the number of dendritic cells, follicular T helper cells and antibody-secreting cells","volume":"96","author":"Liu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.117508_bib197","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12017-019-08558-2","article-title":"Beneficial effects of fingolimod in alzheimer's disease: molecular mechanisms and therapeutic potential","volume":"21","author":"Angelopoulou","year":"2019","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.ejmech.2025.117508_bib198","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2415","article-title":"Sphingosine-1-phosphate related signalling pathways manipulating virus replication","volume":"33","author":"Zhang","year":"2023","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ejmech.2025.117508_bib199","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3390\/v11121097","article-title":"Emerging connections of S1P-metabolizing enzymes with host defense and immunity during virus infections","volume":"11","author":"Wolf","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2025.117508_bib200","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/jamaneurol.2014.3390","article-title":"Fingolimod and risk of varicella-zoster virus infection: back to the future with an old infection and a new drug","volume":"72","author":"Tyler","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejmech.2025.117508_bib201","doi-asserted-by":"crossref","first-page":"18029","DOI":"10.1002\/jcp.28434","article-title":"FTY720 alleviates coxsackievirus B3-induced myocarditis and inhibits viral replication through regulating sphingosine 1-phosphate receptors and AKT\/caspase-3 pathways","volume":"234","author":"Wang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejmech.2025.117508_bib202","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jns.2019.06.025","article-title":"Varicella-zoster virus vasculopathy in a multiple sclerosis patient on fingolimod","volume":"403","author":"Muccilli","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ejmech.2025.117508_bib203","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/iub.2795","article-title":"Fingolimod (FTY720), an FDA-approved sphingosine 1-phosphate (S1P) receptor agonist, restores endothelial hyperpermeability in cellular and animal models of dengue virus serotype 2 infection","volume":"76","author":"Modak","year":"2024","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ejmech.2025.117508_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104999","article-title":"Ponesimod suppresses hepatitis B virus infection by inhibiting endosome maturation","volume":"186","author":"Fauzyah","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.117508_bib205","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1021\/acsabm.2c00349","article-title":"Modulating fingolimod (FTY720) anti-SARS-CoV-2 activity using a PLGA-based drug delivery system","volume":"5","author":"Miranda","year":"2022","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.ejmech.2025.117508_bib206","doi-asserted-by":"crossref","first-page":"e753","DOI":"10.1212\/NXI.0000000000000753","article-title":"COVID-19 infection in a patient with multiple sclerosis treated with fingolimod","volume":"7","author":"Barzegar","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ejmech.2025.117508_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102180","article-title":"Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod","volume":"42","author":"Foerch","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.ejmech.2025.117508_bib208","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008679","article-title":"Fingolimod inhibits multiple stages of the HIV-1 life cycle","volume":"16","author":"Resop","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2025.117508_bib209","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1038\/s41467-022-32698-y","article-title":"Limited impact of fingolimod treatment during the initial weeks of ART in SIV-infected rhesus macaques","volume":"13","author":"Pino","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117508_bib210","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molimm.2014.03.018","article-title":"Mast cell plasticity and sphingosine-1-phosphate in immunity, inflammation and cancer","volume":"63","author":"Oskeritzian","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejmech.2025.117508_bib211","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/all.13310","article-title":"Mast cells and sphingosine-1-phosphate underlie prelesional remodeling in a mouse model of eczema","volume":"73","author":"Wedman","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.ejmech.2025.117508_bib212","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/ijms19051279","article-title":"S1P4 regulates passive systemic anaphylaxis in mice but is dispensable for canonical IgE-mediated responses in mast cells","volume":"19","author":"Kulinski","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117508_bib213","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1096\/fj.08-128900","article-title":"Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors","volume":"23","author":"Price","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2025.117508_bib214","article-title":"Distinct spatial and temporal roles for Th1, Th2, and Th17 cells in asthma","volume":"13","author":"Luo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117508_bib215","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3389\/fimmu.2017.01336","article-title":"Toll-Like receptor 4 is essential for the expression of sphingosine-1-phosphate-dependent asthma-like disease in mice","volume":"8","author":"Roviezzo","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117508_bib216","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23266","article-title":"Fingolimod attenuates ovalbumin-induced airway inflammation via inhibiting MAPK\/ERK signaling in mice","volume":"37","author":"Makled","year":"2023","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117508_bib217","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.951361","article-title":"Contribution of circulatory cells to asthma exacerbations and lung tissue-resident CD4 T cell memory","volume":"13","author":"Sethi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117508_bib218","doi-asserted-by":"crossref","first-page":"L651","DOI":"10.1152\/ajplung.00050.2024","article-title":"Downregulation of protein phosphatase 2A\u03b1 in asthmatic airway smooth muscle","volume":"326","author":"Reza","year":"2024","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejmech.2025.117508_bib219","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/all.13212","article-title":"Targeting PP2A and proteasome activity ameliorates features of allergic airway disease in mice","volume":"72","author":"Nair","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.ejmech.2025.117508_bib220","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/all.12082","article-title":"Topical treatment targeting sphingosine-1-phosphate and sphingosine lyase abrogates experimental allergic rhinitis in a murine model","volume":"68","author":"Kleinjan","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.ejmech.2025.117508_bib221","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.alit.2015.10.009","article-title":"Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment (fingolimod) in NC\/Nga mice","volume":"65","author":"Tsuji","year":"2016","journal-title":"Allergol. Int."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:10:01Z","timestamp":1762265401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425002739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":221,"alternative-id":["S0223523425002739"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117508","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential capacities of FTY720: Novel therapeutic functions, targets, and mechanisms against diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117508"}}